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Objective: The purpose of this study was to determine the minimum
hematocrit value that can support whole body oxygen consumption during
normothermic cardiopulmonary bypass. The effect of hemodilution on
peripheral resistance, whole body oxygen delivery, and oxygen consumption
was determined over a range of hematocrit values. Methods: Measurements
were obtained during 38° C cardiopulmonary bypass with progressive
normovolemic hemodilution (hematocrit value 40% to 9%) in nine dogs.
Dextran 70 (6%) was used as a diluent. Anesthesia consisted of high-dose
fentanyl and midazolam. A mean arterial pressure of 60 mm Hg was
maintained throughout cardiopulmonary bypass via increases in pump
flow. Results: Progressive hemodilution was associated with a decreasing
total peripheral resistance. During normothermic cardiopulmonary bypass
with a whole blood prime, the whole body oxygen consumption approxi-
mated values previously reported in dogs under nonbypass conditions.
Oxygen delivery and whole body oxygen uptake were maintained between a
hematocrit value of 39% and 25%. Significant decreases for both were seen
when the hematocrit value was reduced to 18% and below. Conclusions: A
hematocrit level greater than 18% was needed to maintain systemic oxygen
delivery and consumption during warm cardiopulmonary bypass. The
critical hematocrit value may be higher under bypass than nonbypass
conditions because the flow increases that are practical during cardiopul-
monary bypass do not approximate those seen in response to hemodilution
of the intact circulation. Finally, the critical hematocrit value for the body
may be higher than that required for the brain during warm cardiopulmo-
nary bypass. (J Thorac Cardiovasc Surg 1998;115:1203-8)
Although hemodilution is standard practice duringcardiopulmonary bypass (CPB), the limits of
hemodilution at differing extracorporeal tempera-
tures have not yet been systematically determined.1
The purpose of this study was to define the minimal
hematocrit value that supports whole body oxygen
consumption during normothermic CPB.
The systemic response to hemodilution under
non-CPB conditions is well described. Under nor-
mal conditions, systemic and regional oxygen con-
sumption is independent of oxygen delivery. Oxygen
delivery and consumption are maintained during
moderate hemodilution by increases in cardiac out-
put, increases in tissue blood flow, and later by an
increase in tissue oxygen extraction.2-4 However, for
the individual organ and the body as a whole, there
is a critical hematocrit value at which oxygen con-
sumption becomes delivery-dependent. In the dog,
under non-CPB conditions, systemic oxygen con-
sumption is maintained to a hematocrit value of
approximately 10%.5 The same physiology is appli-
cable during CPB, during which whole body oxygen
balance is actively manipulated by changes in he-
matocrit value, temperature, and pump flow.
Transfusion practice varies greatly in cardiac sur-
gery and improved transfusion guidelines are
needed.6, 7 These issues are made more pressing
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with the shift to normothermic CPB in the past few
years.8, 9 Given the higher oxygen demand associ-
ated with “warm” CPB,10 there is a tendency to
transfuse more frequently, but this practice is not
based on a systematic evaluation of hemoglobin
requirements. In fact, variability in transfusion prac-
tice arises in part because the relationship between
temperature, hematocrit level, and oxygen balance
has not been adequately characterized.
In evaluating the relationships between hemato-
crit value, systemic oxygen consumption, and oxygen
delivery during normothermic CPB, we hope to
provide a more physiologic foundation on which to
make decisions on perfusion and hematocrit man-
agement during CPB.
Materials and methods
After review and approval by the Institutional Animal
Care and Use Committee of the Mayo Clinic, nine
unmedicated fasting adult mongrel dogs weighing 17 to 20
kg were studied. The dogs were placed in an acrylic plastic
box (Plexiglas box, Rohm and Haas Company, Philadel-
phia, Pa.) and anesthesia was induced with halothane 3%
to 4% inspired. After the onset of anesthesia, peripheral
intravenous access was secured, muscle relaxation was
obtained with pancuronium (0.1 mg z kg21), and the tra-
chea was intubated. Ventilation was controlled with a
Harvard pump (Harvard Apparatus Co., Inc., S. Natick,
Mass.) set to maintain arterial carbon dioxide tension
(PaCO2) at 35 to 40 mm Hg and an arterial oxygen tension
(PaO2) greater than 150 mm Hg. Anesthesia was main-
tained with isoflurane 0.5% to 1.5% inspired and fentanyl
and midazolam (bolus: 250 mg z kg–1 fentanyl and 350 mg z
kg–1 midazolam, followed by infusion: fentanyl 3.0 mg z
kg–1 z min–1 and midazolam 9.6 mg z kg–1 z min–1). Muscle
relaxation was maintained by continuous infusion of pan-
curonium (0.8 mg z kg–1 z min–1).
A cannula was surgically inserted into a femoral artery
for mean arterial blood pressure measurements and blood
sampling. Body temperature was measured with a naso-
pharyngeal thermistor.
For CPB, a left-sided thoracotomy was performed.
Venous drainage to the extracorporeal circuit was by a
36F cannula placed in the right atrium via the right atrial
appendage. The blood was circulated by centrifugal pump
through a combined heat exchanger–oxygenator (Bentley
Univox, Irvine, Calif.) and returned via a cannula (4.4 mm
inner diameter) into the root of the aorta. Before aortic
cannulation, intravenous heparin was given to maintain an
activated coagulation time greater than 600 seconds. The
bypass machine was primed with blood (approximately
750 ml) from a donor dog and with saline solution (about
250 ml). Mean arterial pressure was maintained between
55 and 70 mm Hg throughout the period of bypass by
altering bypass pump flow. No vasoconstrictors or vasodi-
lators were used. Arterial hemoglobin concentration,
blood temperature, and blood gas data were continuously
monitored by in-line detectors (CDI 100 and CDI 400,
Cardiovascular Devices, Inc., Tustin, Calif.). Pump flow
was measured with an in-line ultrasonic blood flowmeter
(Sarns/3M, Ann Arbor, Mich.).
After establishment of CPB, control measurements and
blood samples were obtained after the target nasopharyn-
geal temperature of 37.5° C to 38.5° C (low normal dog
temperature) was achieved. Arterial blood was drawn
from the femoral line and mixed venous blood was drawn
from the venous return line just proximal to the CPB
reservoir. Arterial and venous oxygen and carbon dioxide
partial pressures (PO2, PCO2) and pH were measured with
an IL 1306 pH and blood gas analyzer (Instrumentation
Laboratories, Inc., Lexington, Mass.) with the electrodes
maintained at 37° C. Hemoglobin concentration and oxy-
gen saturation were measured by an IL 482 Co-Oximeter
(Instrumentation Laboratories) with its coefficient setting
selected for canine blood. Venous lactate levels were
measured with a YSI model 23A analyzer (Yellow Springs
Instrumentation, Yellow Springs, Ohio).
Oxygen consumption, oxygen delivery, oxygen extrac-
tion ratio, and total peripheral resistance were calculated
by means of standard equations.
Oxygen consumption (V˙O2):
V˙O2 5
~Pump flow z AVDO2!
BSA
ml O2 z min–1 z m–2
where BSA 5 body surface area.
Arteriovenous oxygen content difference (AVDO2):
AVDO2 5 ~CaO2 – CvO2! ml z dl–1
Arterial or venous oxygen content (CxO2):
CxO2 5 1.34 Hb~SxO2! 1 0.003 ~PxO2!
where Hb 5 hemoglobin concentration; SVo2 5 oxygen
saturation; Pxo2 5 partial pressure of oxygen; and x 5
arterial or venous.
Fig. 1. Total peripheral resistance (TPR) in dynes z
sec z cm–5 versus hematocrit (Hct) during the five CPB
study periods. Values are mean 6 standard deviation (n 5
9). A regression curve was generated from 45 individual
values of TPR at individual hematocrit values.
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Oxygen delivery (DO2):
DO2 5
Pump flow z CaO2
BSA
ml O2 z min–1 z m–2
Oxygen extraction ratio (OER):
OER 5
V˙O2
DO2
Total peripheral resistance (TPR):
TPR 5
~MAP – CVP! z 80
Pump flow
dynes z sec z cm–5
where MAP 5 mean arterial pressure and CVP 5 central
venous pressure.
An oversized (36F) venous cannula (for a 20 kg dog)
was placed in the right atrium to ensure complete right
heart drainage such that the central venous pressure could
be assumed to be negligible.
Hemodilution was achieved by removing blood from
the CPB circuit and replacing it with 6% dextran 70. After
each reduction in hematocrit value, a period of hemody-
namic stabilization of at least 15 minutes was allowed
before blood samples were withdrawn and measurements
recorded. Mixed venous oxygen saturation was also mon-
itored for stability before measurement recording and
blood sampling.
Statistical analysis. All physiologic and metabolic data
collected at the five levels of hemodilution during CPB
were analyzed by means of repeated-measures analysis of
variance. Differences between the five periods (with pe-
riod 1 designated as control) were determined by the
Student-Newman-Keuls test when necessary. All values
are expressed as mean 6 standard deviation. Regression
curves for oxygen delivery, oxygen consumption, and total
peripheral resistance were generated from the 45 individ-
ual data points for each variable at each measured hemat-
ocrit value. The data were fit to a logarithmic curve by
means of the formula y 5 a 1 b (lnx). The figures present
these curves, as well as mean values and standard devia-
tions for each variable.
Results
As hematocrit value was reduced from 40% to
9%, systemic physiologic variables remained stable
(Table I). Throughout CPB, temperature, mean
arterial pressure, PaO2, PaCO2, and pH remained
unchanged. The pH tended to decrease in the final
hemodilution step, but this decrease did not reach
statistical significance (Table I).
Progressive hemodilution resulted in a progres-
sive reduction in total peripheral resistance (Fig. 1,
Table II). However, mean arterial pressure was
maintained at approximately 62 mm Hg throughout
the study by increases in pump flow. A 50% increase
in pump flow was required to maintain mean arterial
pressure as hematocrit value was reduced from 39%
to 18% (Table II). The oxygen delivery at a hemat-
ocrit value of 23% was 274 ml z min–1 z m–2 (11.5
ml z kg–1 z min–1) and did not differ from the oxygen
delivery at a hematocrit value of 39%. Only when
hematocrit concentration was reduced to 18% 6 2%
was there a significant decrease in systemic oxygen
delivery to 238 ml z min–1 z m–2 (10 ml z kg–1 z min–1).
Similarly, systemic oxygen consumption was stable
between hematocrit values of 39% and 25% and
showed a significant reduction at a hematocrit value
of 18% and below (Table II, Fig. 2).
During normothermic CPB with a hematocrit
value of 39%, the venous oxygen saturation was
57%. This tended to decrease with progressive
hemodilution and was 50% or less when the hemat-
ocrit value was 18% or below. The oxygen extraction
ratio also tended to rise throughout CPB and in-
creased from 41% to approximately 55% as hemo-
globin concentration was progressively reduced.
Changes in venous lactate parallel changes in the
oxygen extraction ratio (Table II).
Discussion
The beneficial effects of hemodilution during
CPB are well recognized. CPB hemodilution re-
duces the demand for blood therapy and may reduce
the incidence of transfusion-related complications.
Under both CPB and non-CPB conditions, hemodi-
lution increases blood flow in a variety of organ
beds.2, 4, 11, 12 This effect may be particularly advan-
Fig. 2. Whole body oxygen consumption (V˙O2) (h) in
ml z min–1 z m–2 and oxygen delivery (Do2) (n) in ml z
min–1 z m–2 versus hematocrit (Hct) during the five CPB
study periods. Values are mean 6 standard deviation (n 5
9). Each regression curve was generated from 45 individ-
ual values of oxygen consumption and oxygen delivery at
individual hematocrit levels.
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tageous during hypothermic CPB when the reduc-
tion in blood viscosity with hemodilution13 counter-
acts the effect of cold-induced vasoconstriction and
the increased blood viscosity associated with re-
duced body temperature.14
As a result of the reports of the Toronto investi-
gators in 1991,8, 9 there has been a shift toward
normothermic CPB across North America. With
this shift, there was a tendency at our institution and
others to require higher hematocrit values during
CPB, but this practice change was not based on
systematic physiologic data on oxygen balance. Gen-
erally, guidelines as to “temperature appropriate
hematocrit” would be of practical relevance but are
largely lacking. Even for institutions not practicing
warm CPB, patients approximate normothermia in
the initial and late phases of CPB. During these
periods hematocrit may be of particular relevance.
Typically, hemodilution during normothermic
CPB results in hypotension, and it is common
practice to support mean arterial pressure with a
vasoconstrictor. In this investigation, we chose to
increase pump flow to maintain mean arterial pres-
sure rather than use an alpha agonist, for two
reasons. First, supporting arterial pressure with
pump flow allowed us to characterize the relation-
ship between hematocrit value and peripheral resis-
tance during CPB. Second, under non-CPB condi-
tions the response to hemodilution is an increase in
cardiac output rather than systemic vasoconstric-
tion; as such, an increase in pump flow more closely
mimics the physiologic response in the intact circu-
lation. During CPB at equivalent blood pressures,
tissue perfusion should be better maintained with
increases in flow than with addition of a vasocon-
strictor.15
Our study was designed to identify the minimal
hematocrit level that supports whole body oxygen
consumption during normothermic CPB. We found
that systemic oxygen consumption is maintained at a
hematocrit value of 25% but was reduced at 18%.
Interestingly, this range was higher than the re-
ported “critical” hematocrit level of approximately
10% under non-CPB conditions.5 However, we
found that during warm CPB, the critical oxygen
delivery was approximately 10 ml z 100 gm–1 z min–1.
This is essentially the same as the value reported by
Cain5 (9.8 ml z 100 gm–1 z min–1) under non-CPB
conditions. From this observation, two conclusions
may be drawn: First, CPB per se does not alter the
critical level of oxygen transport; second, and more
important, a higher hematocrit value may be indi-
cated under CPB than non-CPB conditions. In the
intact dog, the same critical oxygen delivery is
obtained at a much lower hematocrit value (10%)
because the intact animal is better able to increase
its cardiac output than we are able to increase CPB
pump flow. In our study, at a hematocrit value of
18%, the mean pump flow was 2.9 (or 122 ml z
kg–1 z min–1). Cain’s dogs reached the same critical
oxygen delivery when the hematocrit value was
approximately 10% because the cardiac output was
300 ml z kg–1 z min–1, a cardiac index of about 6
L z min–1 z m–2. Because there are technical limita-
tions to increasing CPB flows much above 2.6 or 2.8
L z min–1 z m–2, oxygen delivery may be compro-
mised by the limited “cardiac output” response to
reduced hematocrit during clinical CPB.
We also found that the critical hematocrit value
for the body during warm CPB is higher than that
reported for the brain under the same conditions.16
In a different study, we determined that cerebral
oxygen demand in dogs is met with a hematocrit
value as low as 15%. We anticipated that the body
would be more tolerant of hemodilution than the
brain because of its lower oxygen demand per unit
weight and higher oxidative reserve. However, the
brain is very effective in increasing its flow at low
hematocrit values such that cerebral perfusion is
maintained by shunting flow from other organ
beds.17, 18 In this way, systemic oxygenation is com-
promised before cerebral oxygenation.
Table I. Systemic physiologic variables with progressive hemodilution during normothermic CPB
CPB period
Hct
(%)
Temp
(°C)
MAP
(mm Hg)
PaO2
(mm Hg)
PaCO2
(mm Hg) pH
1 39 6 6 38 6 0.9 62 6 10 253 6 93 36 6 3 7.35 6 0.06
2 25 6 2 38.5 6 0.8 62 6 4 302 6 105 37 6 4 7.33 6 0.07
3 18 6 2* 38.0 6 0.3 62 6 3 260 6 83 34 6 3 7.35 6 0.04
4 14 6 1* 38.1 6 0.5 62 6 5 279 6 93 37 6 3 7.33 6 0.06
5 9 6 1* 38.1 6 0.5 62 6 5 290 6 63 37 6 6 7.31 6 0.04
Data are mean 6 standard deviation (n 5 9). CPB, Cardiopulmonary bypass; Hct, hematocrit value; Temp, temperature; MAP, mean arterial pressure.
*p , 0.05 versus CPB period 1.
The Journal of Thoracic and
Cardiovascular Surgery
May 1998
1 2 0 6 Liam et al.
Our study might be criticized for several reasons.
First, a pre-CPB systemic oxygen consumption was
not reported. However, our pre-hemodilution value
is consistent with previously reported values in dogs
under non-CPB conditions. In the foundation work
by Starr19 in 1959, the same value was documented
before CPB. Our systemic oxygen consumption dur-
ing CPB period 1 also falls between the values
reported by Gutierrez and associates20 and Cain5
under non-CPB conditions. Therefore the systemic
oxygen consumption of the initial CPB period can
be expected to closely approximate the animal’s
oxygen consumption before CPB.
Second, the oxygen extraction ratio was higher
(41%) and oxygen saturation lower (57%) than
might be expected during CPB with a whole blood
prime. Although in the normal range, the values
during the initial period of CPB (hematocrit value
39%) suggest that either the mean arterial pressure
or pump flow may have been somewhat low relative
to systemic oxygen consumption. We targeted a
mean arterial pressure of 60 mm Hg to reflect
clinical perfusion practice. However, a dog, like the
adult patient with cardiac disease, typically has a
mean arterial pressure closer to 80 mm Hg under
non-CPB conditions. As such, higher mean arterial
pressures or pump flows may be appropriate under
normothermic conditions, particularly as hematocrit
is reduced.
Most studies of this type also face a methodologic
limitation. As in our study, the determination of
systemic oxygen consumption and oxygen delivery
may be linked mathematically as well as physiolog-
ically. This is of particular importance when corre-
lations are performed, and this potential problem
can be minimized by determination of linked or
coupled variables using independent techniques.21
Our laboratory, like most others reporting similar
studies, is unable to provide calorimetric studies or
direct measurements of systemic oxygen consump-
tion and so is compelled to rely on the Fick method.
However, we do realize the inherent limitation of
the technique.
Finally, we provide an assessment of systemic
oxygen balance at five levels of hematocrit but
cannot clearly identify the single lowest acceptable
hematocrit level for warm CPB. Our data indicate
that a hematocrit value of 18% is too low with
conventional CPB but that 25% is adequate. Ideally,
oxygen balance at a hematocrit level between these
values would have been determined. However, on
the basis of non-CPB studies, we expected that the
“critical” hematocrit value would be lower than 18%
and we were surprised by the finding that critical
oxygen delivery is reached at a higher hematocrit
value under CPB than non-CPB conditions. This
finding suggests that the minimal acceptable hemat-
ocrit value is not a fixed number but will vary within
a range, in large part a function of the CPB flow. At
a fixed flow, a critical hematocrit value might be
more rigidly defined, but if flow adjustments are
made, a lower (or higher) hematocrit level will be
critical. Nonetheless, until certain practical limita-
tions in CPB circuitry are overcome, the critical
hematocrit value closely approximates 18% to 20%
at normothermia with conventional flow rates.
In conclusion, we found that CPB does not appear
to alter whole body consumption or critical oxygen
delivery values. We found that whole body oxygen
consumption is not maintained when the hematocrit
value is reduced to 18% during normothermic CPB.
The reason is probably that the increases in pump
flow that are practical during CPB do not approxi-
mate what would be seen under non-CPB conditions
at equivalent hematocrit levels. It is important to
emphasize that we do not define what is a “safe”
hematocrit value under normothermic conditions;
many physiologic aberrations can be tolerated for
Table II. Effect of hemodilution on total peripheral resistance, pump flow, and whole body oxygen balance
during normothermic CPB
CPB period
TPR
(dynes z s z cm25)
Pump flow
(L z min21 z m22)
DO2
(ml z min21 z m22)
V˙O2
(ml z min21 z m22)
OER
(%)
SVO2
(%)
Lactate
(mmol z ml21)
1 3390 6 900 1.9 6 0.5 327 6 69 131 6 31 41 6 7 57 6 7 3.3 6 0.8
2 2760 6 640* 2.3 6 0.4 274 6 54 134 6 21 50 6 7 52 6 5 3.1 6 0.8
3 2370 6 840* 2.9 6 0.9* 238 6 69* 108 6 17* 49 6 16 49 6 12 3.4 6 1.5
4 1990 6 570* 3.4 6 0.9* 217 6 61* 106 6 13* 52 6 13 50 6 13 3.9 6 1.9
5 1740 6 570* 3.8 6 1.1* 182 6 48* 93 6 30* 54 6 18 47 6 13 4.6 6 2.1*
Data are mean 6 standard deviation (n 5 9). CPB, Cardiopulmonary bypass; TPR, total peripheral resistance; DO2, total oxygen delivery; V˙O2, whole body
oxygen consumption; OER, oxygen extraction ratio; SVO2, mixed venous oxygen saturation.
*p , 0.05 versus CPB period 1.
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brief periods of time, but it must also be kept in
mind that normal dogs will tolerate a lower hemat-
ocrit value than today’s older adult patient under-
going cardiac surgery. Nonetheless, we hope these
findings begin to provide a better physiologic frame-
work for our clinical practice.
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